Pierre Lemieux

Chief Operating Officer & Chief Scientific Officer at Acasti Pharma, Inc.

Pierre Lemieux

Pierre Lemieux

Chief Operating Officer & Chief Scientific Officer at Acasti Pharma, Inc.

Overview
Career Highlights

Acasti Pharma, Inc.
Technologie BiolActis, Inc.

RelSci Relationships

99

Number of Boards

5

Birthday

1965

Age

55

Contact Data
Trying to get in touch with Pierre Lemieux? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Pierre Lemieux likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at FlipNpik

Relationship likelihood: Strong

President & Chief Financial Officer at IntelGenx Technologies Corp.

Relationship likelihood: Strong

Former Vice President-Operations & Co-Founder at Technologie BiolActis, Inc.

Relationship likelihood: Strong

Former Director of Finance & Vice President, Finance & Administration at AEterna Zentaris, Inc.

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at Ceapro, Inc.

Relationship likelihood: Strong

Chief Executive Officer, Chief Financial Officer & Vice President at Immunotec, Inc.

Relationship likelihood: Strong

Director & Vice President at BioQuebec

Relationship likelihood: Strong

Founder at BioContact (Québec), Inc.

Relationship likelihood: Strong

President, Chief Executive Officer, Secretary & Director at Acasti Pharma, Inc.

Relationship likelihood: Strong

Executive Chairman at Acasti Pharma, Inc.

Relationship likelihood: Strong

Paths to Pierre Lemieux
Potential Connections via
Relationship Science
You
Pierre Lemieux
Chief Operating Officer & Chief Scientific Officer at Acasti Pharma, Inc.
Education
Post-Doctoral in Oncology

The University of Texas Health Science Center at San Antonio serves San Antonio and the 50,000 square-mile area of South Texas. It extends to campuses in the metropolitan border communities of Laredo and the Rio Grande Valley. More than 3,000 students a year train in an environment that involves more than 100 affiliated hospitals, clinics and health care facilities in South Texas. The UT Health Science Center and its Cancer Therapy & Research Center hold diversity as a core value. In this context, they are mindful of all aspects of human differences, such as socioeconomic status, race, ethnicity, language, nationality, sex, gender identity, sexual orientation, religion, geography, disability and age. At the UT Health Science Center and CTRC, inclusion is a core element for successfully achieving diversity, as they strive to create a climate that fosters belonging, respect and value for all. As an equal employment opportunity and affirmative action employer, the UT Health Science Center and CTRC exercise these core values of diversity and inclusion by promoting and ensuring equal employment opportunity for all individuals without regard to race, color, religion, sex, national origin, age, sexual orientation, disability, or veteran status.

Career History
Chief Operating Officer & Chief Scientific Officer
2002 - Current

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.

Director & Vice President
1999 - Prior

Supratek Pharma, Inc. develops drugs and related oncology therapeutic products. It offers injectable chemotherapeutic that enhances or enables an approved anticancer drug. The firm’s products include SP1014C - a novel cabazitaxel against drug resistant prostate cancer, SP1030C - novel bendamustine against chronic lymphocytic leukemia and non-Hodgkin’s lymphoma and SP1049C - a novel injectable anthracycline platform drug against chemoresistant cancers. The company was founded by Valery Alakhov in 1994 and is headquartered in Pointe-Claire, Canada.

Co-Founder
1998 - 2009

Technologie BiolActis, Inc. engages in the development of biologics for the wellness industries. It specializes in the development of natural peptide mixtures for treatment and prevention of diseases like lipid and cardio-vascular disorders and metabolic syndrome. The company was founded by Eric M. Simard and Pierre Lemieux in 1998 and is headquartered in Laval, Canada.

Investments
Details Hidden

Technologie BiolActis, Inc. engages in the development of biologics for the wellness industries. It specializes in the development of natural peptide mixtures for treatment and prevention of diseases like lipid and cardio-vascular disorders and metabolic syndrome. The company was founded by Eric M. Simard and Pierre Lemieux in 1998 and is headquartered in Laval, Canada.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pierre Lemieux. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pierre Lemieux's profile does not indicate a business or promotional relationship of any kind between RelSci and Pierre Lemieux.